A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.

MLA

Bastepe, Murat, et al. “A Form of Jansen’s Metaphyseal Chondrodysplasia with Limited Metabolic and Skeletal Abnormalities Is Caused by a Novel Activating Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation.” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 7, July 2004, pp. 3595–600. EBSCOhost, https://doi.org/10.1210/jc.2004-0036.

APA

Bastepe, M., Raas-Rothschild, A., Silver, J., Weissman, I., Wientroub, S., Jüppner, H., & Gillis, D. (2004). A form of Jansen’s metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation. The Journal of Clinical Endocrinology and Metabolism, 89(7), 3595–3600. https://doi.org/10.1210/jc.2004-0036

Chicago

Bastepe, Murat, Annick Raas-Rothschild, Justin Silver, Irit Weissman, Shlomo Wientroub, Harald Jüppner, and David Gillis. 2004. “A Form of Jansen’s Metaphyseal Chondrodysplasia with Limited Metabolic and Skeletal Abnormalities Is Caused by a Novel Activating Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Mutation.” The Journal of Clinical Endocrinology and Metabolism 89 (7): 3595–3600. doi:10.1210/jc.2004-0036.